The odds that these three famous, wealthy investors are wrong about the same stock probably aren't very high.The old saying that "birds of a feather flock together" doesn't always apply to the world of the super-wealthy. Rich investors often follow their own paths rather than buying the same assets. So when several of them gravitate to the same stock, it's worthy of notice.An example of such herding occurred recently. Billionaires Warren Buffett and David Tepper, as well as investor Michael Burry (featured ...

Group 1 - UnitedHealth Group's shares experienced a significant rebound, closing at $304.01, up nearly 12% for the day and 20% for the week [1] - The rally was driven by a regulatory filing revealing that Berkshire Hathaway acquired approximately 5 million shares of UnitedHealth, valued at about $1.57 billion [3] - Recent stock purchases by members of Congress, particularly Representative Tim Moore and Representative Marjorie Taylor Greene, occurred just before the stock's rally, raising concerns about potential insider trading [4][6] Group 2 - UnitedHealth has faced challenges including leadership changes and the suspension of financial guidance, while also cooperating with federal investigations related to its Medicare Advantage business [8] - Despite these challenges, UnitedHealth remains the largest provider of Medicare Advantage plans, covering over 8 million individuals, and its Optum division continues to grow in care and technology services [9]

Core Viewpoint - SelectQuote (NYSE: SLQT) faces a securities class action lawsuit following a significant drop in share price after the U.S. Department of Justice (DOJ) intervened in a lawsuit alleging illegal kickbacks and misleading business practices [1][4]. Group 1: Lawsuit Details - The class action lawsuit, Pahlkotter v. SelectQuote, Inc. et al., seeks to represent investors who acquired SelectQuote securities between September 9, 2020, and May 1, 2025 [1][2]. - The lawsuit focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. Group 2: Allegations Against SelectQuote - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote received "tens of millions of dollars" in illegal kickbacks from health insurers for directing Medicare beneficiaries to specific plans [4]. - SelectQuote is accused of failing to provide unbiased comparisons of Medicare plans and instead directing beneficiaries to plans that compensated the company the most, regardless of quality [4][6]. - The company allegedly did not comply with applicable laws and regulations, making it vulnerable to sanctions, including violations of the federal False Claims Act [6]. Group 3: Impact on Share Price - Following the DOJ's announcement on May 1, 2025, SelectQuote's shares plummeted by 19% and have continued to decline amid ongoing legal challenges [1][5].

Financial Performance & Growth - Clover Health anticipates insurance revenue of $1.8 billion to $1.875 billion for full year 2025[50] - The company projects Adjusted EBITDA between $50 million and $70 million for full year 2025[9, 50] - Clover Health expects a 32% year-over-year increase in Medicare Advantage (MA) membership in 2025[9, 44] - Clover Health's Insurance Benefits Expense Ratio (BER) for the first half of 2025 was 87.3%[24] Clover Assistant & Clinical Outcomes - Clover Assistant (CA) is associated with earlier diagnosis of Chronic Kidney Disease (CKD) by approximately 18 months on average[18] - Clover Assistant is associated with 15% lower all-cause hospitalizations and 18% lower 30-day readmissions for members with Chronic Obstructive Pulmonary Disease (COPD)[18, 20] - Clover Health achieved a 4.94 out of 5 Stars on HEDIS measures for Star Rating year 2025, the top-performing score on core HEDIS measures for Medicare Advantage plans with over 2,000 members nationwide[18] Strategic Initiatives - Clover Health is focused on a ~$500 billion market with over 35 million seniors enrolled in Medicare Advantage[8] - Clover Health's Counterpart Health subsidiary aims to expand the company's care model to more plans and providers[8] - Approximately 97% of Clover Health's membership is enrolled in PPO plans[8, 49]

Second Quarter 2025 Earnings Conference Call August 5, 2025 LGTMs: Date: Andrew T. (Input) Verbal LGTM 8/1 Peter K. LGTM 8/1 af Legal (Karen / Peter R.) LGTM 8/4 Accounting (#s confirm) LGTM (7/31 - Joe) Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net income ...

Financial Performance & Guidance - The company's Q2 earnings missed expectations, coming in at $408 per share [1] - 2025 earnings guidance is at least $16 per share, lower than the street's expectation of at least $18 per share [2] Optum Health Performance - Optum Health's Q2 revenues decreased by 7% [2] - Optum Health's full-year revenue is projected to decrease by 4% [3] Factors Impacting Performance - The company faces higher costs, higher utilization, and headwinds in Medicare Advantage plans [2] - V28 reshuffling of billing for Medicare visits is negatively impacting the 90,000-strong doctor unit [3] Leadership & Transparency - Steven Hemsley replaced Andrew Witty as CEO to restore confidence through transparency [1]

Core Insights - Berkshire Hathaway's cash position reached nearly $348 billion at the end of Q1, indicating a significant amount of capital available for investment [1] - Warren Buffett is struggling to find stocks that meet his stringent investment criteria, but UnitedHealth Group is highlighted as a potential opportunity [2][6] Company Understanding - Buffett emphasizes investing only in businesses he thoroughly understands, with insurance being a key area of expertise for him [4] - Berkshire Hathaway generates a substantial portion of its revenue from its property and casualty insurance business, aligning with Buffett's investment philosophy [4] UnitedHealth Group Overview - UnitedHealth Group is the largest health insurer in the U.S., and Buffett has previously invested in the company, indicating familiarity with its operations [5] - The company's share price has dropped over 50% this year, and it has faced challenges with lower-than-expected results and guidance [6] Financial Metrics - UnitedHealth Group's return on equity (ROE) stands at 22.7%, exceeding Buffett's preferred threshold of 20% [7] - Despite disappointing Q1 results, the company reported a revenue increase of $9.8 billion year-over-year, totaling $109.6 billion, and generated a profit of nearly $6.3 billion [8] Valuation and Future Outlook - UnitedHealth Group trades at approximately 12 times trailing earnings, a valuation that may appeal to Buffett compared to when he first invested in 2006 [9] - The primary issue for UnitedHealth is higher-than-expected costs for Medicare Advantage plans, but Buffett may believe the company can address these through premium increases and return to growth by 2026 [11] Investment Consideration - While it is uncertain if Buffett is currently buying UnitedHealth stock, the company fits his investment strategy, which has proven successful over the years [12][13] - Investors looking to emulate Buffett may consider purchasing shares of UnitedHealth Group while it is undervalued [13]

Core Viewpoint - UnitedHealth Group is currently under investigation by the Department of Justice for potential civil fraud related to its Medicare Advantage plans, which has led to a decline in its stock price [1][2][4]. Group 1: Investigation Details - The investigation focuses on how UnitedHealth records diagnoses that result in additional payments for its Medicare Advantage plans [2][7]. - A federal criminal health care-fraud unit is examining the company's practices involving doctors and nurses in gathering diagnoses to enhance payments [4]. - UnitedHealth has stated it is cooperating with federal investigators and has a history of responsible conduct and compliance [1][4]. Group 2: Business Overview - UnitedHealth's UnitedHealthcare division is the largest provider of Medicare Advantage plans, covering over 8 million individuals [3][4]. - The company generated more than $400 billion in revenue last year, ranking as the third-largest company in the Fortune 500 [5]. - The company also operates a growing Optum business that provides care and technology support [5]. Group 3: Stock Performance - UnitedHealth's stock price has decreased significantly, dropping 54% from its all-time high of over $630, with a recent price of $287.39 [5][8]. - The decline in stock value has been exacerbated by a spike in healthcare usage and a subsequent cut in the company's forecast earlier this year [8]. - The company is set to report its second-quarter results next Tuesday, which may further impact stock performance [8].

Core Insights - A federal court ruling has increased Alignment Healthcare's Arizona HMO 2025 star rating from 3.5 to 4 stars, resulting in 100% of its Medicare Advantage members being enrolled in plans rated 4 stars or higher [1][2] Company Overview - Alignment Healthcare serves approximately 217,500 Medicare beneficiaries across five states: Arizona, California, Nevada, North Carolina, and Texas [3] - The company has received accolades such as a 4.9 out of 5-star Google rating and being named a Newsweek World's Most Trustworthy Company 2024 [3] Quality of Care - The Star Ratings program evaluates Medicare Advantage plans annually on a 5-star scale based on various quality measures, including preventive care, chronic disease management, customer service, and member satisfaction [2] - Plans that achieve 4 stars or higher qualify for bonus payments from CMS, which are reinvested to enhance member benefits and services [2] Strategic Positioning - The court's decision affirms the quality of care provided by Alignment Healthcare and enhances the confidence of Arizona members in their plan's quality [2] - The company aims to deliver more value to its members and provider partners, reinforcing its commitment to high-quality Medicare Advantage services [3] Mission and Values - Alignment Health focuses on empowering seniors to age well and live vibrant lives, emphasizing high-quality, low-cost care for its Medicare Advantage members [4] - The company partners with trusted local providers to deliver coordinated care, supported by a customized care model and a 24/7 concierge care team [4]

Core Viewpoint - GoHealth, Inc. has amended its credit agreement with lenders to provide covenant adjustments and extend the maturity of its revolving credit facility until September 30, 2025, aiming to strengthen its financial foundation and support future growth [1][2]. Group 1: Financial Adjustments - The amendment allows GoHealth to pursue receivables financing, including a securitization transaction, as part of a comprehensive financing plan to address its going concern position [1][2]. - The company has received broad-based support from stakeholders, enabling it to focus on long-term strategic priorities [2]. Group 2: Company Overview - GoHealth is a leading health insurance marketplace focused on Medicare, utilizing a technology platform that employs machine-learning algorithms to match health plans to consumer needs [3]. - The company has facilitated the enrollment of millions of consumers in Medicare plans since its inception, emphasizing its role in helping consumers navigate complex health insurance options [3].